Expression profile of IGHG1 in omics data
| ID | GSE120596 |
| Title | Variability in the Analgesic Response to Ibuprofen Following Third Molar Extraction is Associated with Differences in Activation of the Cyclooxygenase Pathway |
| Organism | Homo sapiens |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM3405450 | 1001_baseline | cell type: peripheral blood mononuclear cell subject: 1001 gender: Female timepoint: baseline library barcode: ATTACTCG-TATAGCCT drug treatment: ibuprofen sodium response group: Partial responder | 663.0 |
| GSM3405451 | 1001_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1001 gender: Female timepoint: post-surgery 1 library barcode: TCCGGAGA-TATAGCCT drug treatment: ibuprofen sodium response group: Partial responder | 1495.0 |
| GSM3405452 | 1002_baseline | cell type: peripheral blood mononuclear cell subject: 1002 gender: Female timepoint: baseline library barcode: CGCTCATT-TATAGCCT drug treatment: Placebo response group: Placebo | 569.0 |
| GSM3405453 | 1002_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1002 gender: Female timepoint: post-surgery 1 library barcode: GAGATTCC-TATAGCCT drug treatment: Placebo response group: Placebo | 345.0 |
| GSM3405454 | 1003_baseline | cell type: peripheral blood mononuclear cell subject: 1003 gender: Male timepoint: baseline library barcode: ATTCAGAA-TATAGCCT drug treatment: ibuprofen sodium response group: Full responder | 173.0 |
| GSM3405455 | 1003_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1003 gender: Male timepoint: post-surgery 1 library barcode: GAATTCGT-TATAGCCT drug treatment: ibuprofen sodium response group: Full responder | 175.0 |
| GSM3405456 | 1004_baseline | cell type: peripheral blood mononuclear cell subject: 1004 gender: Male timepoint: baseline library barcode: CTGAAGCT-TATAGCCT drug treatment: ibuprofen sodium response group: Partial responder | 903.0 |
| GSM3405457 | 1004_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1004 gender: Male timepoint: post-surgery 1 library barcode: TAATGCGC-TATAGCCT drug treatment: ibuprofen sodium response group: Partial responder | |
| GSM3405458 | 1005_baseline | cell type: peripheral blood mononuclear cell subject: 1005 gender: Male timepoint: baseline library barcode: CGGCTATG-TATAGCCT drug treatment: Placebo response group: Placebo | 129.0 |
| GSM3405459 | 1005_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1005 gender: Male timepoint: post-surgery 1 library barcode: TCCGCGAA-TATAGCCT drug treatment: Placebo response group: Placebo | |
| GSM3405460 | 1006_baseline | cell type: peripheral blood mononuclear cell subject: 1006 gender: Male timepoint: baseline library barcode: TCTCGCGC-TATAGCCT drug treatment: ibuprofen sodium response group: Partial responder | 289.0 |
| GSM3405461 | 1006_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1006 gender: Male timepoint: post-surgery 1 library barcode: AGCGATAG-TATAGCCT drug treatment: ibuprofen sodium response group: Partial responder | 210.0 |
| GSM3405462 | 1007_baseline | cell type: peripheral blood mononuclear cell subject: 1007 gender: Male timepoint: baseline library barcode: ATTACTCG-ATAGAGGC drug treatment: ibuprofen sodium response group: Full responder | |
| GSM3405463 | 1007_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1007 gender: Male timepoint: post-surgery 1 library barcode: TCCGGAGA-ATAGAGGC drug treatment: ibuprofen sodium response group: Full responder | |
| GSM3405464 | 1008_baseline | cell type: peripheral blood mononuclear cell subject: 1008 gender: Male timepoint: baseline library barcode: CGCTCATT-ATAGAGGC drug treatment: Placebo response group: Placebo | |
| GSM3405465 | 1008_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1008 gender: Male timepoint: post-surgery 1 library barcode: GAGATTCC-ATAGAGGC drug treatment: Placebo response group: Placebo | |
| GSM3405466 | 1008_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1008 gender: Male timepoint: post-surgery 2 library barcode: ATTCAGAA-ATAGAGGC drug treatment: Placebo response group: Placebo | |
| GSM3405467 | 1011_baseline | cell type: peripheral blood mononuclear cell subject: 1011 gender: Female timepoint: baseline library barcode: GAATTCGT-ATAGAGGC drug treatment: ibuprofen sodium response group: Full responder | 285.0 |
| GSM3405468 | 1011_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1011 gender: Female timepoint: post-surgery 1 library barcode: CTGAAGCT-ATAGAGGC drug treatment: ibuprofen sodium response group: Full responder | |
| GSM3405469 | 1011_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1011 gender: Female timepoint: post-surgery 2 library barcode: TAATGCGC-ATAGAGGC drug treatment: ibuprofen sodium response group: Full responder | |
| GSM3405470 | 1012_baseline | cell type: peripheral blood mononuclear cell subject: 1012 gender: Female timepoint: baseline library barcode: CGGCTATG-ATAGAGGC drug treatment: ibuprofen sodium response group: Partial responder | 764.0 |
| GSM3405471 | 1012_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1012 gender: Female timepoint: post-surgery 1 library barcode: TCCGCGAA-ATAGAGGC drug treatment: ibuprofen sodium response group: Partial responder | 934.0 |
| GSM3405472 | 1012_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1012 gender: Female timepoint: post-surgery 2 library barcode: TCTCGCGC-ATAGAGGC drug treatment: ibuprofen sodium response group: Partial responder | |
| GSM3405473 | 1014_baseline | cell type: peripheral blood mononuclear cell subject: 1014 gender: Male timepoint: baseline library barcode: AGCGATAG-ATAGAGGC drug treatment: Placebo response group: Placebo | 402.0 |
| GSM3405474 | 1014_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1014 gender: Male timepoint: post-surgery 1 library barcode: ATTACTCG-CCTATCCT drug treatment: Placebo response group: Placebo | 411.0 |
| GSM3405475 | 1014_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1014 gender: Male timepoint: post-surgery 2 library barcode: TCCGGAGA-CCTATCCT drug treatment: Placebo response group: Placebo | 363.0 |
| GSM3405476 | 1015_baseline | cell type: peripheral blood mononuclear cell subject: 1015 gender: Male timepoint: baseline library barcode: CGCTCATT-CCTATCCT drug treatment: ibuprofen sodium response group: Full responder | 211.0 |
| GSM3405477 | 1015_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1015 gender: Male timepoint: post-surgery 1 library barcode: GAGATTCC-CCTATCCT drug treatment: ibuprofen sodium response group: Full responder | 160.0 |
| GSM3405478 | 1015_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1015 gender: Male timepoint: post-surgery 2 library barcode: ATTCAGAA-CCTATCCT drug treatment: ibuprofen sodium response group: Full responder | 207.0 |
| GSM3405479 | 1016_baseline | cell type: peripheral blood mononuclear cell subject: 1016 gender: Male timepoint: baseline library barcode: GAATTCGT-CCTATCCT drug treatment: ibuprofen sodium response group: Full responder | 385.0 |
| GSM3405480 | 1016_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1016 gender: Male timepoint: post-surgery 1 library barcode: CTGAAGCT-CCTATCCT drug treatment: ibuprofen sodium response group: Full responder | 383.0 |
| GSM3405481 | 1016_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1016 gender: Male timepoint: post-surgery 2 library barcode: TAATGCGC-CCTATCCT drug treatment: ibuprofen sodium response group: Full responder | 445.0 |
| GSM3405482 | 1017_baseline | cell type: peripheral blood mononuclear cell subject: 1017 gender: Male timepoint: baseline library barcode: CGGCTATG-CCTATCCT drug treatment: Placebo response group: Placebo | 435.0 |
| GSM3405483 | 1017_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1017 gender: Male timepoint: post-surgery 1 library barcode: TCCGCGAA-CCTATCCT drug treatment: Placebo response group: Placebo | 677.0 |
| GSM3405484 | 1017_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1017 gender: Male timepoint: post-surgery 2 library barcode: TCTCGCGC-CCTATCCT drug treatment: Placebo response group: Placebo | 766.0 |
| GSM3405485 | 1018_baseline | cell type: peripheral blood mononuclear cell subject: 1018 gender: Female timepoint: baseline library barcode: AGCGATAG-CCTATCCT drug treatment: ibuprofen sodium response group: Full responder | 1417.0 |
| GSM3405486 | 1018_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1018 gender: Female timepoint: post-surgery 1 library barcode: ATTACTCG-GGCTCTGA drug treatment: ibuprofen sodium response group: Full responder | 2054.0 |
| GSM3405487 | 1018_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1018 gender: Female timepoint: post-surgery 2 library barcode: TCCGGAGA-GGCTCTGA drug treatment: ibuprofen sodium response group: Full responder | 2061.0 |
| GSM3405488 | 1019_baseline | cell type: peripheral blood mononuclear cell subject: 1019 gender: Male timepoint: baseline library barcode: CGCTCATT-GGCTCTGA drug treatment: ibuprofen sodium response group: Full responder | 592.0 |
| GSM3405489 | 1019_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1019 gender: Male timepoint: post-surgery 1 library barcode: GAGATTCC-GGCTCTGA drug treatment: ibuprofen sodium response group: Full responder | 469.0 |
| GSM3405490 | 1019_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1019 gender: Male timepoint: post-surgery 2 library barcode: ATTCAGAA-GGCTCTGA drug treatment: ibuprofen sodium response group: Full responder | 569.0 |
| GSM3405491 | 1020_baseline | cell type: peripheral blood mononuclear cell subject: 1020 gender: Female timepoint: baseline library barcode: GAATTCGT-GGCTCTGA drug treatment: Placebo response group: Placebo | |
| GSM3405492 | 1020_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1020 gender: Female timepoint: post-surgery 1 library barcode: CTGAAGCT-GGCTCTGA drug treatment: Placebo response group: Placebo | 275.0 |
| GSM3405493 | 1020_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1020 gender: Female timepoint: post-surgery 2 library barcode: TAATGCGC-GGCTCTGA drug treatment: Placebo response group: Placebo | 398.0 |
| GSM3405494 | 1021_baseline | cell type: peripheral blood mononuclear cell subject: 1021 gender: Female timepoint: baseline library barcode: CGGCTATG-GGCTCTGA drug treatment: ibuprofen sodium response group: Partial responder | 410.0 |
| GSM3405495 | 1021_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1021 gender: Female timepoint: post-surgery 1 library barcode: TCCGCGAA-GGCTCTGA drug treatment: ibuprofen sodium response group: Partial responder | 413.0 |
| GSM3405496 | 1021_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1021 gender: Female timepoint: post-surgery 2 library barcode: TCTCGCGC-GGCTCTGA drug treatment: ibuprofen sodium response group: Partial responder | 345.0 |
| GSM3405497 | 1022_baseline | cell type: peripheral blood mononuclear cell subject: 1022 gender: Male timepoint: baseline library barcode: AGCGATAG-GGCTCTGA drug treatment: ibuprofen sodium response group: Full responder | 308.0 |
| GSM3405498 | 1022_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1022 gender: Male timepoint: post-surgery 1 library barcode: ATTACTCG-AGGCGAAG drug treatment: ibuprofen sodium response group: Full responder | 138.0 |
| GSM3405499 | 1022_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1022 gender: Male timepoint: post-surgery 2 library barcode: TCCGGAGA-AGGCGAAG drug treatment: ibuprofen sodium response group: Full responder | 399.0 |
| GSM3405500 | 1023_baseline | cell type: peripheral blood mononuclear cell subject: 1023 gender: Male timepoint: baseline library barcode: CGCTCATT-AGGCGAAG drug treatment: Placebo response group: Placebo | 600.0 |
| GSM3405501 | 1023_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1023 gender: Male timepoint: post-surgery 1 library barcode: GAGATTCC-AGGCGAAG drug treatment: Placebo response group: Placebo | 407.0 |
| GSM3405502 | 1023_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1023 gender: Male timepoint: post-surgery 2 library barcode: ATTCAGAA-AGGCGAAG drug treatment: Placebo response group: Placebo | 464.0 |
| GSM3405503 | 1024_baseline | cell type: peripheral blood mononuclear cell subject: 1024 gender: Female timepoint: baseline library barcode: GAATTCGT-AGGCGAAG drug treatment: ibuprofen sodium response group: Partial responder | 522.0 |
| GSM3405504 | 1024_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1024 gender: Female timepoint: post-surgery 1 library barcode: CTGAAGCT-AGGCGAAG drug treatment: ibuprofen sodium response group: Partial responder | 538.0 |
| GSM3405505 | 1024_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1024 gender: Female timepoint: post-surgery 2 library barcode: TAATGCGC-AGGCGAAG drug treatment: ibuprofen sodium response group: Partial responder | 626.0 |
| GSM3405506 | 1026_baseline | cell type: peripheral blood mononuclear cell subject: 1026 gender: Female timepoint: baseline library barcode: CGGCTATG-AGGCGAAG drug treatment: Placebo response group: Placebo | 1192.0 |
| GSM3405507 | 1026_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1026 gender: Female timepoint: post-surgery 1 library barcode: TCCGCGAA-AGGCGAAG drug treatment: Placebo response group: Placebo | 1150.0 |
| GSM3405508 | 1026_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1026 gender: Female timepoint: post-surgery 2 library barcode: TCTCGCGC-AGGCGAAG drug treatment: Placebo response group: Placebo | 1350.0 |
| GSM3405509 | 1027_baseline | cell type: peripheral blood mononuclear cell subject: 1027 gender: Female timepoint: baseline library barcode: AGCGATAG-AGGCGAAG drug treatment: Placebo response group: Placebo | 1022.0 |
| GSM3405510 | 1027_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1027 gender: Female timepoint: post-surgery 1 library barcode: ATTACTCG-TAATCTTA drug treatment: Placebo response group: Placebo | 1069.0 |
| GSM3405511 | 1027_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1027 gender: Female timepoint: post-surgery 2 library barcode: TCCGGAGA-TAATCTTA drug treatment: Placebo response group: Placebo | 762.0 |
| GSM3405512 | 1028_baseline | cell type: peripheral blood mononuclear cell subject: 1028 gender: Male timepoint: baseline library barcode: CGCTCATT-TAATCTTA drug treatment: ibuprofen sodium response group: Partial responder | 115.0 |
| GSM3405513 | 1028_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1028 gender: Male timepoint: post-surgery 1 library barcode: GAGATTCC-TAATCTTA drug treatment: ibuprofen sodium response group: Partial responder | 167.0 |
| GSM3405514 | 1028_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1028 gender: Male timepoint: post-surgery 2 library barcode: ATTCAGAA-TAATCTTA drug treatment: ibuprofen sodium response group: Partial responder | 145.0 |
| GSM3405515 | 1029_baseline | cell type: peripheral blood mononuclear cell subject: 1029 gender: Male timepoint: baseline library barcode: GAATTCGT-TAATCTTA drug treatment: ibuprofen sodium response group: Partial responder | 357.0 |
| GSM3405516 | 1029_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1029 gender: Male timepoint: post-surgery 1 library barcode: CTGAAGCT-TAATCTTA drug treatment: ibuprofen sodium response group: Partial responder | 396.0 |
| GSM3405517 | 1029_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1029 gender: Male timepoint: post-surgery 2 library barcode: TAATGCGC-TAATCTTA drug treatment: ibuprofen sodium response group: Partial responder | 532.0 |
| GSM3405518 | 1030_baseline | cell type: peripheral blood mononuclear cell subject: 1030 gender: Female timepoint: baseline library barcode: CGGCTATG-TAATCTTA drug treatment: ibuprofen sodium response group: Partial responder | 604.0 |
| GSM3405519 | 1030_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1030 gender: Female timepoint: post-surgery 1 library barcode: TCCGCGAA-TAATCTTA drug treatment: ibuprofen sodium response group: Partial responder | 955.0 |
| GSM3405520 | 1030_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1030 gender: Female timepoint: post-surgery 2 library barcode: TCTCGCGC-TAATCTTA drug treatment: ibuprofen sodium response group: Partial responder | 1095.0 |
| GSM3405521 | 1032_baseline | cell type: peripheral blood mononuclear cell subject: 1032 gender: Female timepoint: baseline library barcode: AGCGATAG-TAATCTTA drug treatment: Placebo response group: Placebo | 552.0 |
| GSM3405522 | 1032_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1032 gender: Female timepoint: post-surgery 1 library barcode: ATTACTCG-CAGGACGT drug treatment: Placebo response group: Placebo | 846.0 |
| GSM3405523 | 1032_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1032 gender: Female timepoint: post-surgery 2 library barcode: TCCGGAGA-CAGGACGT drug treatment: Placebo response group: Placebo | 548.0 |
| GSM3405524 | 1033_baseline | cell type: peripheral blood mononuclear cell subject: 1033 gender: Male timepoint: baseline library barcode: CGCTCATT-CAGGACGT drug treatment: ibuprofen sodium response group: Full responder | 5161.0 |
| GSM3405525 | 1033_post-surgery_1 | cell type: peripheral blood mononuclear cell subject: 1033 gender: Male timepoint: post-surgery 1 library barcode: GAGATTCC-CAGGACGT drug treatment: ibuprofen sodium response group: Full responder | 7235.0 |
| GSM3405526 | 1033_post-surgery_2 | cell type: peripheral blood mononuclear cell subject: 1033 gender: Male timepoint: post-surgery 2 library barcode: ATTCAGAA-CAGGACGT drug treatment: ibuprofen sodium response group: Full responder | 6604.0 |
| ID | GSE12860 |
| Title | Antirheumatic Drug Response in Human Chondrocytes: Potential Molecular Targets to Stimulate Cartilage Regeneration |
| Organism | Homo sapiens |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM322609 | RASF stimulated chondrocytes rep 1 GSM253283 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium | 5.611164799 |
| GSM322610 | RASF stimulated chondrocytes rep 2 GSM253284 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium | 5.4627574305 |
| GSM322611 | NDSF stimulated chondrocytes rep 1 GSM253285 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of NDSF cultured in the same medium | 5.390185016 |
| GSM322612 | NDSF stimulated chondrocytes rep 2 GSM253286 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of NDSF cultured in the same medium | 5.329790475999999 |
| GSM322613 | Chondrocytes stimulated with diclofenac treated RASF rep 1 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with diclofenac for 48h | 5.745436029 |
| GSM322614 | Chondrocytes stimulated with diclofenac treated RASF rep 2 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with diclofenac for 48h | 5.494038618499999 |
| GSM322615 | Chondrocytes stimulated with prioxicam treated RASF rep 1 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with piroxicam for 48h | 5.6819755465 |
| GSM322616 | Chondrocytes stimulated with prioxicam treated RASF rep 2 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with piroxicam for 48h | 5.481076679 |
| GSM322617 | Chondrocytes stimulated with chloroquine phosphate (resochin) treated RASF rep 1 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with chloroquine phosphate (resochin) for 48h | 5.5208840724999995 |
| GSM322618 | Chondrocytes stimulated with chloroquine phosphate (resochin) treated RASF rep 2 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with chloroquine phosphate (resochin) for 48h | 5.559554058 |
| GSM322619 | Chondrocytes stimulated with sodium aurothiomalate (tauredon) treated RASF rep 1 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with sodium aurothiomalate (tauredon) for 48h | 5.707496294 |
| GSM322620 | Chondrocytes stimulated with sodium aurothiomalate (tauredon) treated RASF rep 2 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with sodium aurothiomalate (tauredon) for 48h | 5.570478989 |
| GSM322621 | Chondrocytes stimulated with azathioprine (imurek) treated RASF rep 1 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with azathioprine (imurek) for 48h | 5.39912278 |
| GSM322622 | Chondrocytes stimulated with azathioprine (imurek) treated RASF rep 2 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with azathioprine (imurek) for 48h | 5.517650736 |
| GSM322623 | Chondrocytes stimulated with methotrexate treated RASF rep 1 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with methotrexate for 48h | 5.8638603955 |
| GSM322624 | Chondrocytes stimulated with methotrexate treated RASF rep 2 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with methotrexate for 48h | 5.6088676445 |
| GSM322625 | Chondrocytes stimulated with prednisolone (solu-decortin) treated RASF rep 1 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with prednisolone (solu-decortin) for 48h | 5.5221455514999995 |
| GSM322626 | Chondrocytes stimulated with prednisolone (solu-decortin) treated RASF rep 2 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with prednisolone (solu-decortin) for 48h | 5.452443108 |
| GSM322627 | Chondrocytes stimulated with methylprednisolone (urbason) treated RASF rep 1 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with methylprednisolone (urbason) for 48h | 5.5808980995 |
| GSM322628 | Chondrocytes stimulated with methylprednisolone (urbason) treated RASF rep 2 | Human chondrocytes cultured in RPMI 1640 medium supplemented with 10% human serum, 100ng/ml amphotericin B, 100U/ml penicillin and 100µg/ml streptomycin for 2 passages, 3D cultured for 14 days in alginate beads in presence of 170µM L-ascorbic acid 2-phosphate and subsequently stimulated for 48h with supernatant of RASF cultured in the same medium and treated with methylprednisolone (urbason) for 48h | 5.4312193825 |
| ID | GSE212044 |
| Title | Reversibility of etomidate-induced contractile arrest through activation of myocardial autophagy |
| Organism | Homo sapiens |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6508421 | IPSC-CM cells, DSMO 1 | cell line: Induced pluripotent stem cells (IPSC) cell type: iPSC-derived Cardiomyocytes(IPSC-CM) phenotype: dilated (DCM) disease state: Duchenne Muscular Dystrophy (DMD) treatment: DSMO time: Day 30 | 0.0 |
| GSM6508422 | IPSC-CM cells, DSMO 2 | cell line: Induced pluripotent stem cells (IPSC) cell type: iPSC-derived Cardiomyocytes(IPSC-CM) phenotype: dilated (DCM) disease state: Duchenne Muscular Dystrophy (DMD) treatment: DSMO time: Day 30 | 0.0 |
| GSM6508423 | IPSC-CM cells, DSMO 3 | cell line: Induced pluripotent stem cells (IPSC) cell type: iPSC-derived Cardiomyocytes(IPSC-CM) phenotype: dilated (DCM) disease state: Duchenne Muscular Dystrophy (DMD) treatment: DSMO time: Day 30 | 0.0 |
| GSM6508424 | IPSC-CM cells, Etomidate 1 | cell line: Induced pluripotent stem cells (IPSC) cell type: iPSC-derived Cardiomyocytes(IPSC-CM) phenotype: dilated (DCM) disease state: Duchenne Muscular Dystrophy (DMD) treatment: Etomidate time: Day 30 | 0.0 |
| GSM6508425 | IPSC-CM cells, Etomidate 2 | cell line: Induced pluripotent stem cells (IPSC) cell type: iPSC-derived Cardiomyocytes(IPSC-CM) phenotype: dilated (DCM) disease state: Duchenne Muscular Dystrophy (DMD) treatment: Etomidate time: Day 30 | 7.0 |
| GSM6508426 | IPSC-CM cells, Etomidate 3 | cell line: Induced pluripotent stem cells (IPSC) cell type: iPSC-derived Cardiomyocytes(IPSC-CM) phenotype: dilated (DCM) disease state: Duchenne Muscular Dystrophy (DMD) treatment: Etomidate time: Day 30 | 0.0 |
| GSM6508427 | IPSC-CM cells, Propofol 1 | cell line: Induced pluripotent stem cells (IPSC) cell type: iPSC-derived Cardiomyocytes(IPSC-CM) phenotype: dilated (DCM) disease state: Duchenne Muscular Dystrophy (DMD) treatment: Propofol time: Day 30 | 0.0 |
| GSM6508428 | IPSC-CM cells, Propofol 2 | cell line: Induced pluripotent stem cells (IPSC) cell type: iPSC-derived Cardiomyocytes(IPSC-CM) phenotype: dilated (DCM) disease state: Duchenne Muscular Dystrophy (DMD) treatment: Propofol time: Day 30 | 0.0 |
| GSM6508429 | IPSC-CM cells, Propofol 3 | cell line: Induced pluripotent stem cells (IPSC) cell type: iPSC-derived Cardiomyocytes(IPSC-CM) phenotype: dilated (DCM) disease state: Duchenne Muscular Dystrophy (DMD) treatment: Propofol time: Day 30 | 0.0 |
| ID | GSE4386 |
| Title | Transcriptomics in cardiac surgery |
| Organism | Homo sapiens |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM99229 | H01_S_B1 | male CABG patient, atrial tissue baseline before CABG surgery | 4.8138835596666665 |
| GSM99235 | H01_S_B2 | male CABG patient, atrial tissue, sevoflurane anesthesia, after CABG surgery | 4.8353667410000005 |
| GSM99239 | H02_P_B1 | male CABG patient, atrial tissue baseline before CABG surgery | 4.807480484333333 |
| GSM99241 | H02_P_B2 | male CABG patient, atrial tissue, propofol anesthesia, after CABG surgery | 4.887966005333333 |
| GSM99244 | H03_P_B1 | male CABG patient, atrial tissue baseline before CABG surgery | 4.843405857 |
| GSM99246 | H03_P_B2 | male CABG patient, atrial tissue, propofol anesthesia, after CABG surgery | 4.824916664666667 |
| GSM99247 | H04_P_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.747014155333333 |
| GSM99249 | H04_P_B2 | male CABG patient, atrial tissue, propofol anesthesia, after CABG surgery | 4.795608642666667 |
| GSM99252 | H05_S_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.740266469666667 |
| GSM99253 | H05_S_B2 | male CABG patient, atrial tissue, sevoflurane anesthesia, after CABG surgery | 4.6847929803333335 |
| GSM99255 | H06_S_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.9220558463333335 |
| GSM99257 | H06_S_B2 | male CABG patient, atrial tissue, sevoflurane anesthesia, after CABG surgery | 4.858897563 |
| GSM99258 | H07_S_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.699489976333333 |
| GSM99259 | H07_S_B2 | male CABG patient, atrial tissue, sevoflurane anesthesia, after CABG surgery | 4.809978578333333 |
| GSM99261 | H08_P_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.6905558386666675 |
| GSM99265 | H08_P_B2 | male CABG patient, atrial tissue, propofol anesthesia, after CABG surgery | 4.785947071 |
| GSM99268 | H09_S_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.831987174 |
| GSM99271 | H09_S_B2 | male CABG patient, atrial tissue, sevoflurane anesthesia, after CABG surgery | 4.785003076 |
| GSM99274 | H10_P_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 5.100289556 |
| GSM99277 | H10_P_B2 | male CABG patient, atrial tissue, propofol anesthesia, after CABG surgery | 5.053316351 |
| GSM99280 | H11_S_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.619363118666667 |
| GSM99282 | H11_S_B2 | male CABG patient, atrial tissue, sevoflurane anesthesia, after CABG surgery | 4.5848495133333325 |
| GSM99285 | H12_P_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.841105862 |
| GSM99287 | H12_P_B2 | male CABG patient, atrial tissue, propofol anesthesia, after CABG surgery | 5.0173323263333325 |
| GSM99289 | H13_S_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.7506373470000005 |
| GSM99290 | H13_S_B2 | male CABG patient, atrial tissue, sevoflurane anesthesia, after CABG surgery | 5.0077081869999995 |
| GSM99291 | H14_P_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.841148798666667 |
| GSM99292 | H14_P_B2 | male CABG patient, atrial tissue, propofol anesthesia, after CABG surgery | 4.837400923666666 |
| GSM99293 | H15_S_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.818568823333333 |
| GSM99294 | H15_S_B2 | male CABG patient, atrial tissue, sevoflurane anesthesia, after CABG surgery | 5.01487765 |
| GSM99295 | H16_P_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.921341857 |
| GSM99296 | H16_P_B2 | male CABG patient, atrial tissue, propofol anesthesia, after CABG surgery | 5.072346601333333 |
| GSM99298 | H17_S_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.6580567 |
| GSM99299 | H17_S_B2 | male CABG patient, atrial tissue, sevoflurane anesthesia, after CABG surgery | 4.778272315 |
| GSM99301 | H18_P_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.908446959333333 |
| GSM99302 | H18_P_B2 | male CABG patient, atrial tissue, propofol anesthesia, after CABG surgery | 4.904857396333333 |
| GSM99303 | H19_P_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.738366431333334 |
| GSM99304 | H19_P_B2 | male CABG patient, atrial tissue, propofol anesthesia, after CABG surgery | 4.836890923333333 |
| GSM99305 | H20_S_B1 | male CABG patient, atrial tissue, baseline before CABG surgery | 4.746777522666666 |
| GSM99306 | H20_S_B2 | male CABG patient, atrial tissue, sevoflurane anesthesia, after CABG surgery | 4.638059205 |
| ID | GSE59526 |
| Title | Affymetrix Chip data of the transcriptome of human clinical study for acupuncture mechanisms on rheumatoid arthritis |
| Organism | Homo sapiens |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1438864 | Peripheral blood mononuclear cells from AP group, Patient 2 before therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 53 treatment group: acupuncture+methotrexate time point: before therapy patient id: 2 | 472.9593601502727 |
| GSM1438865 | Peripheral blood mononuclear cells from AP group, Patient 3 before therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 48 treatment group: acupuncture+methotrexate time point: before therapy patient id: 3 | 1402.0549572914545 |
| GSM1438866 | Peripheral blood mononuclear cells from AP group, Patient 6 before therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 36 treatment group: acupuncture+methotrexate time point: before therapy patient id: 6 | 417.39948700872725 |
| GSM1438867 | Peripheral blood mononuclear cells from AP group, Patient 8 before therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 60 treatment group: acupuncture+methotrexate time point: before therapy patient id: 8 | 159.03269218036363 |
| GSM1438868 | Peripheral blood mononuclear cells from AP group, Patient 9 before therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 31 treatment group: acupuncture+methotrexate time point: before therapy patient id: 9 | 1004.2424882966363 |
| GSM1438869 | Peripheral blood mononuclear cells from MTX group, Patient 4 before therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 61 treatment group: methotrexate time point: before therapy patient id: 4 | 946.6946021520001 |
| GSM1438870 | Peripheral blood mononuclear cells from MTX group, Patient 5 before therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 49 treatment group: methotrexate time point: before therapy patient id: 5 | 623.2497451590908 |
| GSM1438871 | Peripheral blood mononuclear cells from MTX group, Patient 7 before therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 35 treatment group: methotrexate time point: before therapy patient id: 7 | 584.8135293580909 |
| GSM1438872 | Peripheral blood mononuclear cells from Patient 1 after 2 weeks acupuncture therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 64 treatment group: acupuncture+methotrexate time point: after 2 weeks therapy patient id: 1 | 175.05687486027273 |
| GSM1438873 | Peripheral blood mononuclear cells from Patient 3 after 2 weeks acupuncture therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 48 treatment group: acupuncture+methotrexate time point: after 2 weeks therapy patient id: 3 | 1325.5973405659092 |
| GSM1438874 | Peripheral blood mononuclear cells from Patient 1 after 3 months acupuncture therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 64 treatment group: acupuncture+methotrexate time point: after 3 months therapy patient id: 1 | 1179.8699411979999 |
| GSM1438875 | Peripheral blood mononuclear cells from Patient 2 after 3 months acupuncture therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 53 treatment group: acupuncture+methotrexate time point: after 3 months therapy patient id: 2 | 700.1158539343636 |
| GSM1438876 | Peripheral blood mononuclear cells from Patient 6 after 3 months acupuncture therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 36 treatment group: acupuncture+methotrexate time point: after 3 months therapy patient id: 6 | 377.79333762818186 |
| GSM1438877 | Peripheral blood mononuclear cells from Patient 8 after 3 months acupuncture therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 60 treatment group: acupuncture+methotrexate time point: after 3 months therapy patient id: | 366.10025026518184 |
| GSM1438878 | Peripheral blood mononuclear cells from Patient 9 after 3 months acupuncture therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 31 treatment group: acupuncture+methotrexate time point: after 3 months therapy patient id: 9 | 206.52336588354547 |
| GSM1438879 | Peripheral blood mononuclear cells from Patient 4 after 3 months MTX therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 61 treatment group: methotrexate time point: after 3 months therapy patient id: 4 | 459.66598257363637 |
| GSM1438880 | Peripheral blood mononuclear cells from Patient 5 after 3 months MTX therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 49 treatment group: methotrexate time point: after 3 months therapy patient id: 5 | 527.31629323 |
| GSM1438881 | Peripheral blood mononuclear cells from Patient 7 after 3 months MTX therapy | cell type: peripheral blood mononuclear cells disease state: rheumatoid arthritis gender: female age: 35 treatment group: methotrexate time point: after 3 months therapy patient id: 7 | 234.33628977954547 |